Flow NeuroscienceCE-marked tDCS headset (depression, prescribed in some markets)Evidence-based assessment
Flow Neuroscience review
Updated 2026-05-21
6.7
/ 10
Not EEG — clinical tDCS for depression, with the strongest regulatory and trial backing in this list.
Reference clinical tDCS — for users with major depression who want a take-home device with regulatory and trial backing.
Flow Neuroscience is a Swedish-built tDCS (transcranial direct-current stimulation) headset paired with a structured cognitive-behavioural programme app, indicated for major depression. CE-marked as a Class IIa medical device in the EU and prescribed within the UK NHS in some pathways. Not EEG — Flow stimulates, not measures — but lives in the consumer brain-training buying conversation. The clinical reference for take-home tDCS in this list.
How we tested: Evidence-based assessment — scored from Flow Neuroscience product documentation, the published Flow tDCS trial record and independent 2026 reviews. Not hands-on tested by ONDA. Included as the clinical tDCS reference point in this category.
tDCS — clinical-grade transcranial direct-current stimulation over the dorsolateral prefrontal cortex. Disclosed stimulation parameters (2 mA, 30-minute sessions); CE-marked Class IIa medical device.
Training programmes and content
8.0
Structured 8-week behavioural-therapy programme paired with stimulation sessions — the strongest content scaffolding in this list because it is built around a clinical protocol.
Insights and analysis quality
6.0
Mood and adherence tracking against validated scales (PHQ-9). Less granular than EEG headsets — Flow tracks symptoms, not brain signal.
Comfort and wearability
7.0
Rigid headset; 30-minute seated sessions. Some users report a transient scalp tingle or itch during stimulation — well-documented and reversible.
App and integration UX
7.5
Polished app with daily check-ins and clinical-grade adherence tracking.
Open data and developer access
4.0
Closed platform — clinical programme design, not a developer environment.
Value
5.5
£399 (~$499) hardware plus monthly therapy-app subscription. NHS routes available in some UK regions reduce out-of-pocket cost.
Pros
+CE-marked Class IIa medical device — the strongest regulatory backing in this list
+Real randomised-trial evidence for depression (published in Brain Stimulation and elsewhere)
Flow Neuroscience is the clinical reference for take-home tDCS — the most regulated, most trial-backed device in this list. CE-marked as a Class IIa medical device in the EU, paired with a structured eight-week behavioural-therapy programme, and prescribed within parts of the UK NHS as a depression-pathway option. The published randomised-trial evidence for tDCS in major depression is real and growing; Flow’s contribution is packaging that into a take-home protocol patients actually complete.
Where it falls short
It is not an EEG headset. Flow stimulates the dorsolateral prefrontal cortex with 2 mA of direct current; it does not measure brain activity. Indication is restricted to major depression — for general focus, meditation or sleep, Flow is the wrong tool. The platform is closed, the price includes a monthly therapy-app subscription on top of the hardware, and outside the UK NHS pathways the full cost is out-of-pocket.
Who it is for
Choose Flow Neuroscience if you have major depression and a clinician open to discussing it as a take-home option. For general brain training, meditation feedback or sleep tracking, this is the wrong category — Muse S Athena and the EEG-based devices are the right shape. Flow is included here as the clinical reference for what regulated, trial-backed brain-targeted hardware looks like.
Background reading
The neuroscience these headsets feed back — and the cognitive states the EEG signal reveals.